Egill Rostrup Selected Research

Phosphodiesterase 5 Inhibitors

1/2020	Tadalafil may improve cerebral perfusion in small-vessel occlusion stroke-a pilot study.
4/2009	Cerebral haemodynamic response or excitability is not affected by sildenafil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Egill Rostrup Research Topics

Disease

27	Schizophrenia (Dementia Praecox) 01/2024 - 05/2012
17	Psychotic Disorders (Schizoaffective Disorder) 03/2024 - 01/2014
5	Cognitive Dysfunction 12/2022 - 09/2014
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2012
3	Migraine Disorders (Migraine) 10/2018 - 04/2009
2	Body Weight (Weight, Body) 01/2022 - 02/2016
2	Stroke (Strokes) 01/2022 - 01/2020
2	Substance-Related Disorders (Drug Abuse) 02/2021 - 01/2019
2	Hyperventilation 01/2020 - 12/2019
2	Epilepsy (Aura) 10/2018 - 01/2016
2	Headache (Headaches) 10/2018 - 04/2009
2	Weight Gain 02/2016 - 08/2012
2	Weight Loss (Weight Reduction) 01/2014 - 08/2012
1	Hallucinations (Hallucination) 01/2024
1	Delirium 01/2021
1	Aphasia (Dysphasia) 01/2020
1	Cerebral Small Vessel Diseases 01/2020
1	Lacunar Stroke 06/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Brain Injuries (Brain Injury) 01/2019
1	Fatigue 01/2019
1	Parkinson Disease (Parkinson's Disease) 12/2018
1	Sleep Deprivation 12/2018
1	Disease Progression 10/2018
1	Migraine with Aura (Familial Hemiplegic Migraine) 10/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 03/2016
1	Mental Disorders (Mental Disorder) 10/2015
1	Obesity 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2014
1	Hyperoxia 09/2013
1	Overweight 08/2012
1	Hypercapnia 04/2009
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2008
1	Synovitis 04/2004

Drug/Important Bio-Agent (IBA)

32	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 05/2012
11	Dopamine (Intropin)FDA LinkGeneric 01/2024 - 12/2012
10	Glutamic Acid (Glutamate)FDA Link 03/2024 - 01/2018
7	gamma-Aminobutyric Acid (GABA)IBA 12/2023 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 02/2008
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 08/2012
2	Glutamine (L-Glutamine)FDA Link 07/2023 - 01/2020
2	Aripiprazole (Abilify)FDA Link 02/2023 - 01/2023
2	Tadalafil (Cialis)FDA Link 12/2022 - 01/2020
2	Exenatide (Byetta)FDA Link 01/2022 - 01/2014
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 04/2009
2	Acetazolamide (Diamox)FDA LinkGeneric 01/2020 - 12/2019
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2020 - 09/2015
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2020 - 04/2009
2	Amisulpride (Solian)IBA 01/2019 - 02/2016
2	Sildenafil Citrate (Viagra)FDA Link 01/2017 - 04/2009
1	BenzodiazepinesIBA 12/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Antidepressive Agents (Antidepressants)IBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2018
1	Cilostazol (Pletal)FDA LinkGeneric 10/2018
1	Ketamine FDA LinkGeneric 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	EsketamineIBA 01/2018
1	DystrophinIBA 01/2017
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Dopamine D2 Receptor AntagonistsIBA 02/2016
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2016
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2016
1	LigandsIBA 01/2016
1	epideprideIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 09/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2014
1	Troleandomycin (TAO)FDA Link 01/2014
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2014
1	HomocysteineIBA 01/2014
1	Oxygen (Dioxygen)IBA 09/2013
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 08/2012
1	Hormones (Hormone)IBA 08/2012
1	C-Reactive ProteinIBA 04/2004

Therapy/Procedure

1	Electrodes (Electrode) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Secondary Prevention 06/2019
1	Aftercare (After-Treatment) 02/2016
1	Subcutaneous Injections 01/2014